Galectin Therapeutics Inc (GALT)
0.782
-0.11
(-12.14%)
USD |
NASDAQ |
Dec 24, 11:00
Galectin Therapeutics Total Liabilities (Quarterly): 121.45M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alaunos Therapeutics Inc | 0.826M |
| SELLAS Life Sciences Group Inc | 10.61M |
| Oragenics Inc | 2.126M |
| Anavex Life Sciences Corp | 11.75M |
| Phathom Pharmaceuticals Inc | 574.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.97M |
| Shareholders Equity (Quarterly) | -92.48M |